These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 12117359

  • 1. Down-regulation of survivin expression in T lymphocytes after interferon beta-1a treatment in patients with multiple sclerosis.
    Sharief MK, Semra YK.
    Arch Neurol; 2002 Jul; 59(7):1115-21. PubMed ID: 12117359
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Upregulated survivin expression in activated T lymphocytes correlates with disease activity in multiple sclerosis.
    Sharief MK, Noori MA, Douglas MR, Semra YK.
    Eur J Neurol; 2002 Sep; 9(5):503-10. PubMed ID: 12220382
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The expression of apoptosis-regulatory proteins in B lymphocytes from patients with multiple sclerosis.
    Seidi OA, Sharief MK.
    J Neuroimmunol; 2002 Sep; 130(1-2):202-10. PubMed ID: 12225903
    [Abstract] [Full Text] [Related]

  • 9. Dynamics of immune cell trafficking in interferon-beta treated multiple sclerosis patients.
    Hartrich L, Weinstock-Guttman B, Hall D, Badgett D, Baier M, Patrick K, Feichter J, Hong J, Ramanathan M.
    J Neuroimmunol; 2003 Jun; 139(1-2):84-92. PubMed ID: 12799025
    [Abstract] [Full Text] [Related]

  • 10. Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients.
    Ferrarini AM, Sivieri S, Buttarello M, Facchinetti A, Perini P, Gallo P.
    Mult Scler; 1998 Jun; 4(3):174-7. PubMed ID: 9762669
    [Abstract] [Full Text] [Related]

  • 11. Disease activity in multiple sclerosis correlates with T lymphocyte expression of the inhibitor of apoptosis proteins.
    Semra YK, Seidi OA, Sharief MK.
    J Neuroimmunol; 2002 Jan; 122(1-2):159-66. PubMed ID: 11777555
    [Abstract] [Full Text] [Related]

  • 12. [Interferon beta and copolymer-1: mechanism of action and clinical effects in multiple sclerosis].
    Losy J.
    Neurol Neurochir Pol; 2000 Jan; 34(3 Suppl):63-9. PubMed ID: 10983302
    [Abstract] [Full Text] [Related]

  • 13. T-cell interferon gamma receptor binding in interferon beta-1b-treated patients with multiple sclerosis.
    Bongioanni P, Lombardo F, Moscato G, Mosti S, Meucci G.
    Arch Neurol; 1999 Feb; 56(2):217-22. PubMed ID: 10025427
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. No induction of apoptosis by IFN-beta in human antigen-specific T cells.
    Zipp F, Beyer M, Gelderblom H, Wernet D, Zschenderlein R, Weller M.
    Neurology; 2000 Jan 25; 54(2):485-7. PubMed ID: 10668719
    [Abstract] [Full Text] [Related]

  • 18. Lymphocyte subpopulations, oxidative burst and apoptosis in peripheral blood cells of patients with multiple sclerosis-effect of interferon-beta.
    Mix E, Stefan K, Höppner J, Klauer T, Zettl UK, Strauss U, Meyer-Rienecker HJ, Rolfs A.
    Autoimmunity; 2003 Aug 25; 36(5):291-305. PubMed ID: 14567559
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.